# FDA Inspection 976513 - KU Leuven Research & Development - April 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/a06bdc97-4414-4940-9d01-61faf6a225f8
Source feed: FDA_Inspections

> FDA Inspection 976513 for KU Leuven Research & Development on April 14, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 976513
- Company Name: KU Leuven Research & Development
- Inspection Date: 2016-04-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1237787 - 2024-05-03](https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/4b1e57a3-eb7f-44ee-b718-9246284bfe9f)
- [FDA Inspection 694809 - 2010-09-16](https://www.keypedia.com/records/fda_inspections/ku-leuven-research-development/7c3eedac-d36a-449d-ab90-9593bddf8b9d)

Company: https://www.keypedia.com/companies/ku-leuven-research-development/7f59b9ed-f3a8-45fc-b588-c322282f8b0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c